Clinical trial
Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
NCT00128115 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00128115 |
|---|---|
| Title | Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) |
| Official title | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hip Fracture |
| Intervention type | Drug |
| Interventions | MK0677 |
| Enrollment | 83 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Aug 9, 2005 |
| Last update posted | Jan 20, 2016 |
| Countries | Germany, Norway, Spain, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: